Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 3 4Phase NA 2Phase 1 2Phase EARLY_PHASE1 1Phase 4 1

Status

Unknown 1Completed 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 17Sarcoma 2Genitourinary 2Gastrointestinal 2CNS 2Thoracic 1Other solid neoplasm 1Other neoplasm 1

Conditions

Gliosarcoma 2Glioblastoma 2Central Nervous System Neoplasms 2Brain Neoplasms 1

Interventions

Temozolomide 62Cyclophosphamide 59Radiotherapy 47Doxorubicin 36Filgrastim 26Irinotecan 24Radiation 23Gemcitabine 23fludarabine 22Magnetic Resonance Spectroscopy 20Imatinib Mesylate 19Etoposide 18pembrolizumab 16Cisplatin 15Carboplatin 15Biopsy 15Bevacizumab 15Specimen Handling 14fludarabine phosphate 12Nivolumab 12Leucovorin 12Ipilimumab 12Granulocyte Colony-Stimulating Factor 12Chemotherapy, Adjuvant 12pazopanib 11Vincristine 11Ifosfamide 11Melphalan 10Erlotinib Hydrochloride 10Docetaxel 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Brachytherapy × Sarcoma × Clear all
NCT00004129 2013-09-17

Phosphorus 32 in Treating Patients With Glioblastoma Multiforme

National Cancer Institute (NCI)

Phase 1 Unknown
12 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00053183 2009-02-09

Surgery Followed by Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

National Cancer Institute (NCI)

Phase 1 Completed
CNSSarcoma

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡